BetterLife Pharma (BETRF) Other Non-Current Assets (2016 - 2020)
BetterLife Pharma (BETRF) posted quarterly Other Non-Current Assets of $192050.0 for Q3 2018, up 6522.41% year-over-year from $2900.0 in Q3 2017, and down 2.18% quarter-over-quarter from $196340.0 in Q2 2018.
BetterLife Pharma (BETRF) Other Non-Current Assets (2016 - 2020) Analysis & Trends
BetterLife Pharma's Other Non-Current Assets history runs 3 years deep, the most recent figure standing at $192050.0 for Q3 2018.
- In Q3 2018, Other Non-Current Assets rose 6522.41% year-over-year to $192050.0; the TTM figure through Jul 2018 stood at $192050.0 (up 6522.41% YoY), while the FY2017 annual figure was $2900.0, changed 0.0% from the prior year.
- Other Non-Current Assets for Q3 2018 stood at $192050.0, down from $196340.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $196340.0 in Q2 2018, with the low at $2900.0 in Q1 2016.
- The 3-year median for Other Non-Current Assets is $2900.0 (2016), against an average of $45410.0.
- The sharpest annual moves came in 2017 and 2018: Other Non-Current Assets changed 0.0% in 2017, then jumped 6670.34% in 2018.
- BetterLife Pharma's Other Non-Current Assets stood at $2900.0 in 2016, then changed by 0.0% to $2900.0 in 2017, then surged by 6522.41% to $192050.0 in 2018.
- Business Quant data shows BETRF's Other Non-Current Assets at $192050.0 in Q3 2018, $196340.0 in Q2 2018, and $2900.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2020 | 126,609.54 |
| Jul 31, 2020 | 129,667.21 |
| Apr 30, 2020 | 129,038.59 |
| Jul 31, 2018 | 192,050.00 |
| Apr 30, 2018 | 196,340.00 |
| Jul 31, 2017 | 2,900.00 |
| Apr 30, 2017 | 2,900.00 |
| Jan 31, 2017 | 2,900.00 |
| Oct 31, 2016 | 2,900.00 |
| Jul 31, 2016 | 2,900.00 |
| Apr 30, 2016 | 2,900.00 |
| Jan 31, 2016 | 2,900.00 |